全文获取类型
收费全文 | 1561篇 |
免费 | 167篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 18篇 |
妇产科学 | 9篇 |
基础医学 | 138篇 |
口腔科学 | 16篇 |
临床医学 | 53篇 |
内科学 | 146篇 |
皮肤病学 | 874篇 |
神经病学 | 18篇 |
特种医学 | 42篇 |
外科学 | 104篇 |
综合类 | 48篇 |
预防医学 | 39篇 |
眼科学 | 1篇 |
药学 | 91篇 |
1篇 | |
中国医学 | 36篇 |
肿瘤学 | 97篇 |
出版年
2023年 | 107篇 |
2022年 | 64篇 |
2021年 | 65篇 |
2020年 | 107篇 |
2019年 | 53篇 |
2018年 | 71篇 |
2017年 | 67篇 |
2016年 | 56篇 |
2015年 | 70篇 |
2014年 | 97篇 |
2013年 | 96篇 |
2012年 | 79篇 |
2011年 | 77篇 |
2010年 | 86篇 |
2009年 | 82篇 |
2008年 | 78篇 |
2007年 | 41篇 |
2006年 | 34篇 |
2005年 | 36篇 |
2004年 | 36篇 |
2003年 | 29篇 |
2002年 | 22篇 |
2001年 | 26篇 |
2000年 | 18篇 |
1999年 | 20篇 |
1998年 | 16篇 |
1997年 | 11篇 |
1996年 | 16篇 |
1995年 | 14篇 |
1994年 | 9篇 |
1993年 | 12篇 |
1992年 | 7篇 |
1990年 | 7篇 |
1989年 | 3篇 |
1988年 | 7篇 |
1987年 | 4篇 |
1986年 | 12篇 |
1985年 | 8篇 |
1984年 | 5篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1974年 | 3篇 |
1970年 | 4篇 |
1967年 | 3篇 |
1965年 | 4篇 |
1958年 | 7篇 |
1956年 | 4篇 |
1954年 | 3篇 |
1925年 | 2篇 |
1921年 | 4篇 |
排序方式: 共有1733条查询结果,搜索用时 31 毫秒
101.
Pichardo-Velázquez P Domínguez-Cherit J Vega-Memije Ma Moreno-Coutiño G Proy H 《International journal of dermatology》2004,43(2):148-150
BACKGROUND: Basal cell carcinoma (BCC) is one of the most frequent malignancies in the general population. Its best treatment option is the complete excision of the lesion. Mohs' micrographic surgery has demonstrated to be the surgical method with the highest cure rates, however, it is not available in many countries or institutions. METHODS: We propose, as a treatment option for high-risk BCC, surgical resection of the tumor with transoperatory histological examination with the hematoxilin-eosin technique, delaying closure of the wounds until the margins and surgical bed are tumor-free. RESULTS: We studied 83 patients with BCC; 49 were treated with the transoperatory technique and delay closure.We observed no recurrence in any patient that we followed up and there were no complications resulting from the technique in a 25-month follow up. CONCLUSIONS: We recommend this technique for tumors with high-risk of recurrence if Mohs' micrographic surgery is not available. 相似文献
102.
Traulsen J 《International journal of dermatology》2004,43(8):611-617
BACKGROUND: Calcipotriol and corticosteroids are commonly used treatments for psoriasis vulgaris, each with different mechanisms of action. The two agents have shown combined action, but current formulations do not permit simultaneous application. Daivobet (LEO Pharma, Denmark) ointment contains calcipotriol and the corticosteroid, betamethasone dipropionate. Such a formulation may provide convenience and enhanced activity compared with separate applications, but it is essential that the biological activity and bioavailability of either active agent is not adversely affected by the other component. OBJECTIVE: His study was designed to determine whether the bioavailability of the corticosteroid component of Daivobet was equivalent to that in a corticosteroid-only formulation (Diprosone, Schering-Plough Laboratories, France). METHOD: A vasoconstrictor assay measuring skin blanching was used to determine bioequivalence. RESULT: Skin blanching measured either by objective chromametric measurement or visual assessment showed Daivobet to be equivalent to Diprosone. CONCLUSION: The data indicate that the steroid component of Daivobet is not unfavorably affected by the calcipotriol. 相似文献
103.
104.
Cappugi P Mavilia L Campolmi P Reali EF Mori M Rossi R 《Journal of chemotherapy (Florence, Italy)》2004,16(5):491-493
Photodynamic therapy (PDT) is a treatment modality using a photosensitizer, light and oxygen to cause photochemically-induced selective cell death. Topical PDT is most suitable for thin lesions such as superficial basal cell carcinoma and actinic keratoses in dermatology. Results with PDT as treatment of thicker lesions such as nodular basal cell carcinoma appear to have a limited role because the photosensitizer or the light cannot penetrate deeply enough into the thicker tumor volume. In this preliminary study we use intralesional administration of 5-aminolevulinic acid to enhance the efficacy of the photosensitivity of nodular basal cell carcinomas, thus improving clinical cure. 相似文献
105.
M Caccialanza R Piccinno M Beretta L Gnecchi 《Journal of the American Academy of Dermatology》1999,41(4):589-594
BACKGROUND: Ionizing radiation therapy has a well-defined role among several therapeutic options available for the management of cutaneous neoplasms. However, many dermatologists today are not aware of its potential. OBJECTIVE: Our purpose was to evaluate the effectiveness and safety of radiotherapy in a large series of patients with primary malignant epithelial neoplasms (PMENs), who had been subjected to radiotherapy between 1982 and 1995. METHODS: A retrospective study was performed on 1188 patients with a total of 2002 PMENs that had been treated by contact, superficial, and intermediate x-ray therapy. RESULTS: Complete remission was obtained in 98.7% of the irradiated lesions. The 5-year cure rate was 90.73%. Cosmetic results were evaluated as "good" or "acceptable" in 84.01% of the treated lesions. Acute complications occurred in 1.94% and chronic complications in 0.34%. To date, neither radio-induced skin neoplasms nor late stochastic effects have been observed. CONCLUSION: This study confirms that dermatologic radiotherapy is an effective and reliable form of treatment of PMENs and has a favorable cure rate/toxicity ratio. 相似文献
106.
《International immunopharmacology》2009,9(6):781-791
The response of the immune system during injury of the central nervous system may play a role in protecting neurons. We have previously reported that immunization with MOG 35–55 prior to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced injury of the dopaminergic system promotes less dopamine depletion and less dopaminergic damage of neurons in mice. In this study, we evaluate the influence of MOG immunization on the inflammatory reaction that occurs at the place of injury. C57Bl male mice, 2 and 12 months old, received i.p. injections of MPTP (40 mg/kg) and some groups animals also received an additional injection with myelin oligodendrocyte glycoprotein (MOG) 35–55 in CFA 6 days before MPTP administration. MPTP caused a common inflammatory reaction characterized by microglial activation, infiltration of T cells into the substantia nigra and striatum and increased expression of mRNA encoding pro-inflammatory cytokines (IL-1β, TNFα, INFγ) and trophic factors (TGFβ, GDNF). MOG immunization prior to MPTP administration significantly diminished the microglial reaction and reduced the levels of infiltrating CD8+ lymphocytes. The number of CD4+ T cells remained at the same level as in the MPTP group. Expression of pro-inflammatory cytokines was diminished. The mRNA expression of GDNF was significantly higher in the MOG pretreated mice relative to the MPTP group, both in the 2 month old and 12 month old groups. Since MOG immunization prior to MPTP intoxication appears to prevent nigrostriatal injury, the observed decrease of inflammation and increase of GDNF mRNA expression in the injured areas might represent one of the mechanisms of observed neuroprotection. 相似文献
107.
AB Kimball U Gieler D Linder F Sampogna RB Warren M Augustin 《Journal of the European Academy of Dermatology and Venereology》2010,24(9):989-1004
Psoriasis is associated with significant physical and psychological burden affecting all facets of a patient’s life – relationships, social activities, work and emotional wellbeing. The cumulative effect of this disability may be self‐perpetuating social disconnection and failure to achieve a ‘full life potential’ in some patients. Health‐related quality of life studies have quantified the burden of psoriasis providing predominantly cross‐sectional data and point‐in‐time images of patients’ lives rather than assessing the possible cumulative disability over a patient’s lifetime. However, social and economic outcomes indicate there are likely negative impacts that accumulate over time. To capture the cumulative effect of psoriasis and its associated co‐morbidities and stigma over a patient’s life course, we propose the concept of ‘Cumulative Life Course Impairment’ (CLCI). CLCI results from an interaction between (A) the burden of stigmatization, and physical and psychological co‐morbidities and (B) coping strategies and external factors. Several key aspects of the CLCI concept are supported by data similar to that used in health‐related quality of life assessments. Future research should focus on (i) establishing key components of CLCI and determining the mechanisms of impairment through longitudinal or retrospective case–control studies, and (ii) assessing factors that put patients at increased risk of developing CLCI. In the future, this concept may lead to a better understanding of the overall impact of psoriasis, help identify more vulnerable patients, and facilitate more appropriate treatment decisions or earlier referrals. To our knowledge, this is a first attempt to apply and develop concepts from ‘Life Course Epidemiology’ to psoriasis research. 相似文献
108.
109.
110.